Assura Plc (LON:AGR – Get Free Report)’s stock price passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 42.69 ($0.54) and traded as low as GBX 40.20 ($0.51). Assura shares last traded at GBX 40.20 ($0.51), with a volume of 4,531,571 shares changing hands.
Analysts Set New Price Targets
A number of analysts have recently weighed in on AGR shares. Peel Hunt cut shares of Assura to an “add” rating and set a GBX 48 ($0.61) price target on the stock. in a report on Wednesday, March 20th. Shore Capital restated a “buy” rating on shares of Assura in a report on Tuesday, May 21st.
Read Our Latest Stock Report on Assura
Assura Stock Down 0.3 %
Assura Increases Dividend
The business also recently announced a dividend, which will be paid on Wednesday, July 10th. Investors of record on Thursday, June 6th will be paid a GBX 0.84 ($0.01) dividend. The ex-dividend date of this dividend is Thursday, June 6th. This is a boost from Assura’s previous dividend of $0.82. This represents a yield of 1.97%. Assura’s dividend payout ratio (DPR) is -30,000.00%.
Insider Buying and Selling
In related news, insider Ed Smith bought 50,486 shares of the stock in a transaction that occurred on Thursday, June 13th. The stock was bought at an average cost of GBX 39 ($0.49) per share, for a total transaction of £19,689.54 ($24,904.55). In other Assura news, insider Ed Smith purchased 50,486 shares of Assura stock in a transaction on Thursday, June 13th. The stock was bought at an average cost of GBX 39 ($0.49) per share, with a total value of £19,689.54 ($24,904.55). Also, insider Jonathan Murphy purchased 198,975 shares of Assura stock in a transaction on Tuesday, May 21st. The shares were acquired at an average cost of GBX 43 ($0.54) per share, with a total value of £85,559.25 ($108,220.66). Insiders purchased 305,721 shares of company stock worth $12,777,613 in the last three months. Corporate insiders own 0.25% of the company’s stock.
About Assura
Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK – caring for more than 600 primary healthcare buildings, from which over six million patients are served. A constituent of the FTSE 250 and the EPRA indices, as at 30 September 2023, Assura's portfolio was valued at £2.7 billion.
Further Reading
- Five stocks we like better than Assura
- How to invest in blue chip stocks
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- What are earnings reports?
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- ESG Stocks, What Investors Should Know
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.